Some of the most prevalent CCA genetic alterations affect well-known cancer drivers such as tumor suppressor TP53, which regulates cell cycle, and KRAS, a tyrosine kinase signaling member [1]. This evidence concerns the gene TP53 and cholangiocarcinoma.